Pharmaceuticals, Biotechnology and Life Sciences
MDxHealth has announced that results from a study published in The Prostate further validated ConfirmMDx for Prostate Cancer and showed that the test can provide treating urologists with deeper insights into a patient`s risk for aggressive prostate cancer.
MDxHealth has signed an agreement with the Faculty of Health, Medicine and Life Sciences / School for Oncology and Developmental Biology (GROW) at Maastricht University to expand its existing research collaboration to develop commercial next generation (epi)genetic cancer diagnostics.
MDxHealth has reported results from a castration resistant prostate cancer (CRPC) treatment study.
US Government Services Administration (GSA) has awarded MDxHealth to supply Department of Veterans Affairs (VA) with ConfirmMDx for Prostate Cancer.
MDxHealth has signed a distribution agreement with AceCGT Life Science Limited for their SelectMDx for Prostate Cancer assay in Hong Kong…